These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12605957)

  • 41. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.
    Abd Elmageed ZY; Naura AS; Errami Y; Zerfaoui M
    Cell Signal; 2012 Jan; 24(1):1-8. PubMed ID: 21840394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ionizing radiations in Caenorhabditis elegans induce poly(ADP-ribosyl)ation, a conserved DNA-damage response essential for survival.
    Dequen F; Gagnon SN; Desnoyers S
    DNA Repair (Amst); 2005 Jul; 4(7):814-25. PubMed ID: 15923155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation.
    Aguilar-Quesada R; Muñoz-Gámez JA; Martín-Oliva D; Peralta-Leal A; Quiles-Pérez R; Rodríguez-Vargas JM; Ruiz de Almodóvar M; Conde C; Ruiz-Extremera A; Oliver FJ
    Curr Med Chem; 2007; 14(11):1179-87. PubMed ID: 17504138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues.
    Johansson M
    Genomics; 1999 May; 57(3):442-5. PubMed ID: 10329013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability.
    Bürkle A
    Cancer Lett; 2001 Feb; 163(1):1-5. PubMed ID: 11163101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span.
    Grube K; Bürkle A
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11759-63. PubMed ID: 1465394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Poly (ADP-ribose) polymerase (PARP) is essential for sulfur mustard-induced DNA damage repair, but has no role in DNA ligase activation.
    Bhat KR; Benton BJ; Ray R
    J Appl Toxicol; 2006; 26(5):452-7. PubMed ID: 16906506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Poly(ADP-ribosa)polymerase--the relationships with life span and carcinogenesis].
    Piskunova TS; Iurova MN; Zabezhinskiĭ MA; Anisimov VN
    Adv Gerontol; 2007; 20(2):82-90. PubMed ID: 18306694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription.
    Lapucci A; Pittelli M; Rapizzi E; Felici R; Moroni F; Chiarugi A
    Mol Pharmacol; 2011 Jun; 79(6):932-40. PubMed ID: 21441600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians.
    Muiras ML; Müller M; Schächter F; Bürkle A
    J Mol Med (Berl); 1998 Apr; 76(5):346-54. PubMed ID: 9587069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors.
    Tentori L; Portarena I; Graziani G
    Pharmacol Res; 2002 Feb; 45(2):73-85. PubMed ID: 11846617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trans-dominant inhibition of poly(ADP-ribosyl)ation leads to decreased recovery from ionizing radiation-induced cell killing.
    Rudat V; Küpper JH; Weber KJ
    Int J Radiat Biol; 1998 Mar; 73(3):325-30. PubMed ID: 9525261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poly(ADP-ribosyl)ation inhibitors: promising drug candidates for a wide variety of pathophysiologic conditions.
    Beneke S; Diefenbach J; Bürkle A
    Int J Cancer; 2004 Oct; 111(6):813-8. PubMed ID: 15300792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?
    Zhang J
    Bioessays; 2003 Aug; 25(8):808-14. PubMed ID: 12879452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defending genomic stability over life span: a proposed role for PARP-1.
    Muiras ML; Bürkle A
    Exp Gerontol; 2000 Sep; 35(6-7):703-9. PubMed ID: 11053660
    [No Abstract]   [Full Text] [Related]  

  • 58. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art.
    De Vos M; Schreiber V; Dantzer F
    Biochem Pharmacol; 2012 Jul; 84(2):137-46. PubMed ID: 22469522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.
    Min W; Cortes U; Herceg Z; Tong WM; Wang ZQ
    Carcinogenesis; 2010 Dec; 31(12):2058-65. PubMed ID: 20926829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding kinetics and activity of human poly(ADP-ribose) polymerase-1 on oligo-deoxyribonucleotide substrates.
    Jorgensen TJ; Chen K; Chasovskikh S; Roy R; Dritschilo A; Uren A
    J Mol Recognit; 2009; 22(6):446-52. PubMed ID: 19585541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.